Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02431559 |
| Title | A Phase 1/2 Study of Motolimod (VTX-2337) and MEDI4736 in Subjects With Recurrent, Platinum-Resistant Ovarian Cancer for Whom Pegylated Liposomal Doxorubicin (PLD) is Indicated |
| Recruitment | Completed |
| Gender | female |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Ludwig Institute for Cancer Research |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | CHE |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Research Facitlity | Phoenix | Arizona | 85016 | United States | Details | |
| Research Facility | New York | New York | 10065 | United States | Details | |
| Research Facility | Hilliard | Ohio | 43026 | United States | Details | |
| Research Facility | Providence | Rhode Island | 02905 | United States | Details | |
| Research Facility | Lausanne | 1011 | Switzerland | Details |